Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

<p>Activating <i>TMPRSS2-ERG</i> fusions and the downstream cistrome are marked by 5hmC. <b>A</b> and <b>B,</b> 5hmC locations and hypomethylation at the <i>ERG</i> and <i>TMPRSS2</i> loci. 5hmC levels are shown as frequency of sample...

Saved in:

書目詳細資料
主要作者:	Martin Sjöström (14845882) (author)
其他作者:	Shuang G. Zhao (12227671) (author), Samuel Levy (14960811) (author), Meng Zhang (14960814) (author), Yuhong Ning (279537) (author), Raunak Shrestha (14949693) (author), Arian Lundberg (14960817) (author), Cameron Herberts (14960820) (author), Adam Foye (14960823) (author), Rahul Aggarwal (14960826) (author), Junjie T. Hua (14960829) (author), Haolong Li (1532230) (author), Anna Bergamaschi (14960832) (author), Corinne Maurice-Dror (14960835) (author), Ashutosh Maheshwari (14960838) (author), Sujun Chen (3553841) (author), Sarah W.S. Ng (14960841) (author), Wenbin Ye (14960844) (author), Jessica Petricca (14960847) (author), Michael Fraser (522709) (author), Lisa Chesner (14960850) (author), Marc D. Perry (14960853) (author), Thaidy Moreno-Rodriguez (14960856) (author), William S. Chen (14960859) (author), Joshi J. Alumkal (14950518) (author), Jonathan Chou (14957015) (author), Alicia K. Morgans (5600567) (author), Tomasz M. Beer (14960862) (author), George V. Thomas (13187926) (author), Martin Gleave (146446) (author), Paul Lloyd (14960865) (author), Tierney Phillips (4664332) (author), Erin McCarthy (14960868) (author), Michael C. Haffner (14960871) (author), Amina Zoubeidi (14960874) (author), Matti Annala (219688) (author), Robert E. Reiter (14960877) (author), Matthew B. Rettig (14960880) (author), Owen N. Witte (14960883) (author), Lawrence Fong (14960886) (author), Rohit Bose (14960889) (author), Franklin W. Huang (10726678) (author), Jianhua Luo (14960892) (author), Anders Bjartell (199682) (author), Joshua M. Lang (12227674) (author), Nupam P. Mahajan (14960895) (author), Primo N. Lara (13009812) (author), Christopher P. Evans (14960898) (author), Phuoc T. Tran (14960901) (author), Edwin M. Posadas (14960904) (author), Chuan He (178952) (author), Xiao-Long Cui (2020402) (author), Jiaoti Huang (88989) (author), Wilbert Zwart (14960907) (author), Luke A. Gilbert (5513207) (author), Christopher A. Maher (14960910) (author), Paul C. Boutros (14954698) (author), Kim N. Chi (14960913) (author), Alan Ashworth (14957030) (author), Eric J. Small (14960916) (author), Housheng H. He (14960919) (author), Alexander W. Wyatt (14960922) (author), David A. Quigley (14957012) (author), Felix Y. Feng (14845891) (author)
出版:	2025
主題:	Cancer Cancer Risk Factors Molecular and Cellular Biology Methods and Technology Epigenetics Epigenomics Genitourinary Cancers Prostate cancer Liquid Biopsy
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
由: Alex Chehrazi-Raffle (17079582)
出版: (2025)

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
由: Alex Chehrazi-Raffle (17079582)
出版: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
由: John Gallon (15096459)
出版: (2025)

Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
由: Arian Lundberg (14960817)
出版: (2025)

Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
由: Arian Lundberg (14960817)
出版: (2025)

Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
由: Arian Lundberg (14960817)
出版: (2025)

Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
由: Arian Lundberg (14960817)
出版: (2025)

Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
由: Arian Lundberg (14960817)
出版: (2025)

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
由: Hong Qiu (14963144)
出版: (2025)

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
由: Hong Qiu (14963144)
出版: (2025)

Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
由: Rongxin Zhang (15293341)
出版: (2025)

Supplementary Table S2 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
由: Rongxin Zhang (15293341)
出版: (2025)

Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
由: Abdullah A. Osman (15056323)
出版: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
由: James R. Larkin (14936324)
出版: (2025)

Supplementary Tables 1 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease
由: Prashant Chittiboina (15367044)
出版: (2025)

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
由: Stephanie Lheureux (16797697)
出版: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
由: Emil Christensen (15054394)
出版: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
由: Emil Christensen (15054394)
出版: (2025)

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
由: Kala Visvanathan (14952973)
出版: (2025)

Figure S5 from Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci
由: Tomas Kanholm (14952351)
出版: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
由: Dipika R. Mohan (15011204)
出版: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
由: Stephanie Lheureux (16797697)
出版: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
由: Stephanie Lheureux (16797697)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_2uvsm5pam7ev5vo57lmdat2piv